Castle Biosciences Inc Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 76.75%85.91%84.54%83.18%76.64%79.53%81.87%
EBT Margin -27.90%10.31%-16.28%-42.53%-50.28%-26.10%6.49%
EBIT Margin -16.83%14.13%-10.44%-42.60%-53.16%-30.93%2.61%
EBITDA Margin -27.94%10.17%-16.42%-33.26%-53.16%-30.93%2.61%
Operating Margin -16.83%14.13%-10.44%-42.60%-53.16%-30.93%2.61%
Net Margin -44.60%5.77%-16.42%-33.26%-48.99%-26.15%5.49%
FCF Margin -55.17%11.72%8.16%-23.88%-34.51%-8.76%11.00%
Efficiency
Inventory Average 1.06M1.73M2.12M3.00M5.96M8.04M
Assets Average 71.08M279.54M450.95M454.95M450.33M492.29M
Equity Average 14.27M250.40M413.72M405.44M395.21M423.55M
Invested Capital -32.07M110.23M415.69M411.74M399.15M391.27M465.86M
Asset Utilization Ratio 0.730.220.210.300.490.67
Leverage & Solvency
Interest Coverage Ratio -1.691.60-2.48-0.04M-0.00M-0.01M15.03
Debt to Equity -0.430.300.02
Debt Ratio 1.090.210.02
Equity Ratio -2.520.710.950.890.890.860.86
Times Interest Earned -1.691.60-2.48-0.04M-0.00M-0.01M15.03
Valuation
Enterprise Value -4.48M487.99M927.19M754.99M361.69M337.63M453.26M
Market Capitalization 586.84M1,337.04M1,084.63M620.32M580.73M746.39M
Return Ratios
Return on Sales -0.28%0.10%-0.16%-0.33%-0.49%-0.26%0.05%
Return on Capital Employed 0.13%-0.03%-0.09%-0.17%-0.17%0.02%
Return on Invested Capital 0.18%-0.08%-0.18%0.02%
Return on Assets 0.07%-0.04%-0.07%-0.15%-0.13%0.04%
Return on Equity 0.37%-0.04%-0.08%-0.17%-0.15%0.04%